These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1395984)

  • 1. Intraperitoneal hyperthermic treatment for peritoneal dissemination of colorectal cancers.
    Yamaguchi A; Tsukioka Y; Fushida S; Kurosaka Y; Kanno M; Yonemura Y; Miwa K; Miyazaki I
    Dis Colon Rectum; 1992 Oct; 35(10):964-8. PubMed ID: 1395984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Continuous hyperthermic peritoneal perfusion with cisplatin and mitomycin C for peritoneal dissemination in gastric cancer].
    Fujimura T; Yonemura Y; Urade M; Sugiyama K; Hasegawa H; Hashimoto T; Miyata R; Matsuda Y; Katayama K; Yamaguchi A
    Nihon Gan Chiryo Gakkai Shi; 1989 Jul; 24(7):1415-24. PubMed ID: 2509604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effectiveness of continuous hyperthermic peritoneal perfusion for the peritoneal dissemination of gastric cancer].
    Akiyama H; Kunisaki C; Nomura M; Matsuda G; Otsuka Y; Ono H; Shimada H
    Gan To Kagaku Ryoho; 2002 Nov; 29(12):2168-73. PubMed ID: 12484029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous hyperthermic peritoneal perfusion for peritoneal carcinomatosis.
    Chung YC; Huang MT; Chang CN; Huang TW
    J Formos Med Assoc; 1996 Feb; 95(2):138-43. PubMed ID: 9064002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperthermo-chemotherapy combined with cytoreductive surgery for the treatment of gastric cancer with peritoneal dissemination.
    Yonemura Y; Fujimura T; Fushida S; Takegawa S; Kamata T; Katayama K; Kosaka T; Yamaguchi A; Miwa K; Miyazaki I
    World J Surg; 1991; 15(4):530-5; discussion 535-6. PubMed ID: 1891941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of continuous hyperthermic peritoneal perfusion for the prophylaxis and treatment of peritoneal metastasis of advanced gastric cancer: evaluation by multivariate regression analysis.
    Hirose K; Katayama K; Iida A; Yamaguchi A; Nakagawara G; Umeda S; Kusaka Y
    Oncology; 1999; 57(2):106-14. PubMed ID: 10461056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic outcomes of continuous hyperthermic peritoneal perfusion against advanced gastric cancer with peritoneal carcinomatosis.
    Kunisaki C; Shimada H; Akiyama H; Nomura M; Matsuda G; Otsuka Y; Ono H; Takahashi M
    Hepatogastroenterology; 2006; 53(69):473-8. PubMed ID: 16795995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of gastric cancer patients with peritoneal metastasis by continuous hyperthermic peritoneal infusion with mitomycin C and cisplatin].
    Yonemura Y; Fujimura T; Takekawa S; Ohoyama S; Kimura H; Kamata T; Katayama K; Matsuki N; Sawa T; Sakuma H
    Gan To Kagaku Ryoho; 1991 Feb; 18(2):271-6. PubMed ID: 1899549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Continuous hyperthermic peritoneal perfusion (CHPP) for prevention or treatment of peritoneal dissemination].
    Kusano H; Miyashita K; Matsuo T; Jibiki M; Nakagoe T; Miura T; Tomita M
    Gan To Kagaku Ryoho; 1993 Aug; 20(11):1622-5. PubMed ID: 8373233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylactic therapy for peritoneal recurrence of gastric cancer by continuous hyperthermic peritoneal perfusion with mitomycin C.
    Koga S; Hamazoe R; Maeta M; Shimizu N; Murakami A; Wakatsuki T
    Cancer; 1988 Jan; 61(2):232-7. PubMed ID: 3121165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of two bi-institutional prospective studies using intraperitoneal oxaliplatin with or without irinotecan during HIPEC after cytoreductive surgery for colorectal carcinomatosis.
    Quenet F; Goéré D; Mehta SS; Roca L; Dumont F; Hessissen M; Saint-Aubert B; Elias D
    Ann Surg; 2011 Aug; 254(2):294-301. PubMed ID: 21772129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIPEC + EPIC versus HIPEC-alone: differences in major complications following cytoreduction surgery for peritoneal malignancy.
    McConnell YJ; Mack LA; Francis WP; Ho T; Temple WJ
    J Surg Oncol; 2013 May; 107(6):591-6. PubMed ID: 23129533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment-related morbidity and toxicity of CRS and oxaliplatin-based HIPEC compared to a mitomycin and doxorubicin-based HIPEC protocol in patients with peritoneal carcinomatosis: a matched-pair analysis.
    Glockzin G; von Breitenbuch P; Schlitt HJ; Piso P
    J Surg Oncol; 2013 May; 107(6):574-8. PubMed ID: 22833286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of efficacy of prophylactic continuous hyperthermic peritoneal perfusion on subsequent peritoneal recurrence and survival in patients with advanced gastric cancer.
    Kunisaki C; Shimada H; Nomura M; Akiyama H; Takahashi M; Matsuda G
    Surgery; 2002 May; 131(5):521-8. PubMed ID: 12019405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Intraperitoneal chemotherapy in gastric cancer patients with peritoneal dissemination].
    Hirono Y; Katayama K; Murakami M; Iida A; Yamaguchi A
    Gan To Kagaku Ryoho; 2005 Oct; 32(10):1404-9. PubMed ID: 16227738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of primary peritoneal mesothelioma by continuous hyperthermic peritoneal perfusion (CHPP).
    Park BJ; Alexander HR; Libutti SK; Wu P; Royalty D; Kranda KC; Bartlett DL
    Ann Surg Oncol; 1999 Sep; 6(6):582-90. PubMed ID: 10493628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous hyperthermic peritoneal perfusion for the treatment of peritoneal dissemination in gastric cancers and subsequent second-look operation.
    Fujimura T; Yonemura Y; Fushida S; Urade M; Takegawa S; Kamata T; Sugiyama K; Hasegawa H; Katayama K; Miwa K
    Cancer; 1990 Jan; 65(1):65-71. PubMed ID: 2104572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperthermic intraperitoneal chemotherapy using a combination of mitomycin C,5-fluorouracil, and oxaliplatin in patients at high risk of colorectal peritoneal metastasis: A Phase I clinical study.
    Shimizu T; Sonoda H; Murata S; Takebayashi K; Ohta H; Miyake T; Mekata E; Shiomi H; Naka S; Tani T
    Eur J Surg Oncol; 2014 May; 40(5):521-528. PubMed ID: 24388411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment results of peritoneal dissemination from gastric cancer by neoadjuvant intraperitoneal-systemic chemotherapy].
    Yonemura Y; Kawamura T; Bando E; Takahashi S; Sawa T; Yoshimitsu Y; Obata T; Endo Y; Sasaki T; Sugarbaker PH
    Gan To Kagaku Ryoho; 2004 Oct; 31(11):1723-6. PubMed ID: 15553695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peritonectomy and hyperthermic antiblastic perfusion in the treatment of peritoneal carcinomatosis.
    Cavaliere F; Di Filippo F; Botti C; Cosimelli M; Giannarelli D; Aloe L; Arcuri E; Aromatario C; Consolo S; Callopoli A; Laurenzi L; Tedesco M; Di Angelo P; Giunta S; Cavaliere R
    Eur J Surg Oncol; 2000 Aug; 26(5):486-91. PubMed ID: 11016471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.